World Marijuana Market Predicted to Enjoy a 47% CAGR for the Next Nine Years
Europe May Become the World’s Largest Medical Marijuana Market
It has been compared to both the Tech Bubble and the South Sea Bubble but marijuana stocks have a habit of rebounding and with good reason. When shortsellers were causing a blip earlier this summer, the Constellation Brands deal with Canopy Growth restored the market.
With a global sales value of US$57 billion predicted by 2027 the international marijuana market is going to gain in value as savvy operators move to take the nascent industry into the international mainstream.
A report by Arcview Market Research and BDS Analytics in February 2018 predicts an explosive growth in medical marijuana consumption across the globe and recreational marijuana in the United States and in Canada. The report, Roadmap to a US$57 Billion Worldwide Market, forecasts that by 2027 global legal marijuana consumption will reach US$57 billion.
According to the roadmap, recreational use will dominate the sales figures at US$38 billion followed by medical marijuana at US$19.1 billion. North American consumption is pegged to lead global markets rising from US$9.2 billion in 2017 to US$47.3billion in 2027.
Globally, Arcview and BDS see the market going from US$52 million in 2017 to US$2.5 billion in 2027 providing ROW markets with a CAGR of 47%. The report points out that Europe, with a population of 739 million and US$1.5 trillion in healthcare spending stands to become the largest medical cannabis market in the world.
Canadian companies have already leveraged their first starter status to move into the international space. Industry leader Canopy Growth (TSX: WEED) has just had its target price upgraded to $74.00 from $56.00 by Cowen and Company analyst Vivien Azer. One of her reasons for raising the target price was that Canopy had the “Ability to establish an early lead in the adult use cannabis market as well as the domestic and international medical marijuana market.”
Through a variety of strategic alliances, investments and ownership, Canopy Growth has operations in Columbia, Brazil, Chile, Germany, Jamaica, Denmark, Germany and Australia. Canopy has never shied away from saying that its corporate agenda is to become the number player in the international medical and recreational marijuana company.
Aurora Cannabis (TSX: ACB) has operations in 14 countries spread across five continents. It recently the creation of a spinoff, Australis, a company designed to make investments in US cannabis and real estate. Aurora raised $17 million in a private placement to finance the investments.
Aprhria, (TSX: APH,) announced in March 2018 that it had purchased Nuuvera a grower and distributer with strong Maritime connections. Aphria paid $525 million to acquire Nuuvera but it was looking far beyond the Maritimes. Some European countries are or will be demanding that medical marijuana be grown in their own countries. Nuuvera has five different country licenses and applications to the table. The company now called Aphria International is a front runner for a German cultivation license.
While many of the Canadian marijuana companies listed on the TSXV and CSE have upgraded and joined the TSX as they prospered, opportunities are still to be had in the small cap sector.
Crop Infrastructure, (CSE: CROP) recently received a positive rating in Forbes in The Three Most Overlooked Marijuana Markets. It earned those kudos on the strength of its Jamaican operation. CROP just announced that Greg Douglas, the former CEO of the Jamaican Cannabis Licensing Authority had joined CROP as a member of the executive advisory board with a special focus on Jamaica.
CROP Infrastructure Corp. loans capital to purchase real estate and build greenhouse infrastructure which is leased to the licensed producers. It also offers management and branding expertise. The company receives a 60% preferential payback via lease and management fees on greenhouse infrastructure related equipment, until its deployed capital is returned in full. Once its investment is repaid in full, CROP’s 30% interest in the real estate and infrastructure will receive dividends indefinitely. The company also has several minority positions in its tenants. CROP is structured like a REIT. It has operations in Nevada, Washington State, California, Jamaica and Italy. Its long-term strategic goal is to operate in every jurisdiction where marijuana or medical marijuana is legal.
CROP operations have started harvesting in Italy and Washington State and this should provide the share price with momentum. Arcview Market Research has pegged Italy as being Europe’s second largest medical marijuana market after Germany. As well CROP has a joint venture in two California dispensary locations, San Bernardino and West Hollywood.
American regulations have also led to American producers listing on Canadian exchanges. The Next Green Wave is to be listed shortly on the CSE after the company successfully raised $21 million in Canadian financing. The company operates in California where recreational marijuana was legalized at the beginning of the year. The California market is expected to be one of the largest in the world.
It has four California licenses that just about cover everything from seeds to cultivation to producing oil and cannabinoids for medical marijuana to distribution. It falls under today’s rubric of European market opportunities because the company is in discussions with European growers about seeds.
Along with its licences NGW has an ace up its sleeve because CEO Mike Jennings has won the High Times Cannabis Cup six times and been inducted into the High Times Seedbank Hall of Fame. High Times is the marijuana growers’ and consumers’ bible. Next Green Wave has a sponsorship agreement with High Times.
Canada legalized medical marijuana in 2001, which eventually led to the legalization of recreational marijuana in 2018. As well, 29 American states have legalized medical and recreational marijuana. Just as the legalization of medical marijuana led to the legalization of recreational marijuana in North America, the industry believes that recreational marijuana will eventually become legalized around the world as more and more jurisdictions legalize medical marijuana.
How soon that will happen is anyone’s guess. Arcview Market Research’s editor in chief Tom Adams believes that will only happen after the American government ends its marijuana prohibition. Only then, he believes, will the United Nations remove marijuana from the United Nations Single Convention on Narcotic Drugs.
The above should not be construed as investment advice. It has been written for education purposes only. Every investor should and must perform their own due diligence.
- Published in Blog, Business, Medical Marijuana, News Home
Crop Advances Dispensary App to Level 3 Review and Hempire’s Harvest Continues With First Sales Pending Testing
Momentum Public Relations
Press Release: September 6, 2018
CROP Infrastructure Corp. (CSE: CROP) (CSE: CROP.CN) (OTC: CRXPF) (“CROP“ or the “Company“) announces it has received confirmation that its San Bernardino dispensary application has advanced to stage three of four of the application review process.
Furthermore, the Company is pleased to announce its 49% “Emerald Triangle” cannabis production facility tenanted by “Hempire” in Humboldt California continues harvest with an additional 2 greenhouses now drying and awaiting test results to begin selling. This 30,000 square foot production facility sits on approximately 8.46 acres and consists of a 10,000 square foot medicinal cannabis greenhouse facility and an additional 20,000 square feet of recreational licensed canopy.
Hempire has also advised they have secured 800 additional ready-to-flower plants for a late season harvest with a unique genetic currently in high demand.
CROP Infrastructure Director & CEO Michael Yorke states: “Crop’s tenant, Hempire’s harvest looks phenomenal and we look forward to receiving the first brand licencing and lease payments from Hempire in September. The Emerald Heights dispensary application is exciting as vertically integrating tenants will provide for the largest returns both from a brand licencing perspective and return on investment from CROP’s real estate portfolio.”
About Humboldt Holdings LLC
Located in Humboldt County, California the property is 8.46 acres and currently houses a 10,000 square foot greenhouse as well as a barn, garage and residence. On site are five 5,000-gallon water tanks, a well and pump house and a 30 x 60 ft. drying shed. The property is zoned for a 10,000 square foot medical and a 20,000 square foot recreational cannabis license.
https://cropcorp.com/property/california/
About CROP
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 15 Cannabis brands and has US and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home
DIAGNOS Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer Disease
Momentum Public Relations
Press Release: September 5, 2018
Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today an agreement to provide a telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics (“Optina”) for a period of 3 years. Optina will use DIAGNOS Cloud services to upload images generated by Optina’s hyperspectral camera for early detection of Alzheimer via key biomarkers in the retina of the eye.
The processed images will be available to be shared and further analysed by healthcare professionals and clinics in various locations. Optina will benefit from the high throughput of DIAGNOS CARA Cloud service as well as the ease of use of the teleophthalmology platform currently used by doctors and other medical professionals.
“At DIAGNOS, we are extremely happy to contribute to the success of innovative Quebec companies like Optina. Optina will leverage our experience and the high quality standard of CARA, a field proven platform approved for sale by the Food and Drug Administration in the United States, Health Canada and other countries’ homologation bodies. This partnership will foster more collaboration with other biotech firms and attract new clients in need of a telemedicine platform.” said Yves-Stephane Couture, Vice-President of sales at DIAGNOS.
“The partnership will greatly accelerate Optina’s commercialization of its Alzheimer diagnostic test, saving critical time to market while providing effective and efficient user experience.” said David Lapointe, President and CEO of Optina.
About Optina
Optina Diagnostics is a Montreal based company focused on the development of technology for the early detection of disease through hyperspectral imaging of the eye. With a first application in the early diagnosis of Alzheimer’s, Optina brings a radiomics approach to biomarker detection.
Additional information about Optina is available at www.optinadx.com.
About DIAGNOS
DIAGNOS is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence (“AI”) tool CARA (Computer Assisted Retina Analysis). CARA is a tele- ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care (“POC”). CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost-effective tool for screening large numbers of patients in real-time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration and the European Union.
Additional information about DIAGNOS is available at www.diagnos.com and www.sedar.com.
For further information, please contact:
André Larente, President
DIAGNOS Inc.
Tel: 450-678-8882 ext. 224
alarente@diagnos.ca
- Published in Business, Diagnos, Life Sciences, News Home, Technology
CROP Subsidiary to Open Italian Retail Locations Launching Its First Line of Hemp Oil Infused Products in Italy
Momentum Public Relations
Press Release: August 30, 2018
CROP Infrastructure Corp. (CSE: CROP) (OTCMKTS: CRXPF) (“CROP” or the “Company”)announces it will launch its first line of Hemp oil infused cosmetic and therapeutic products under the brand “URBAN JUVE”, pursuant to its previously announced License Agreement with The Yield Growth Corp.’s subsidiary, Urban Juve Provisions Inc. (formerly Juve Wellness Inc.). The License Agreement gives CROP exclusive rights in Italy to the URBAN JUVE products, as well as non-exclusive distribution rights in the United States.
Furthermore, the Company in partnership with the team from Xhemplar S.R.L. CROP’s cultivation and extraction joint venture partner in Italy, is scouting locations to open 2 CBD retail outlets in Northern Italy under the company’s Emerald Heights brand, before the end of 2018.
The URBAN JUVE product line which will be featured prominently along with Xhemplar products, and Hempire hemp oil products at all Italy locations. Urban Juve is inspired by Ayurvedic philosophy and is created for the modern, wellness-conscious consumer. The unique formulations benefit consumers seeking natural products made with the highest quality ingredients. Urban Juve is manufacturing its first line of 12 topical products in the fall of 2018. All the products contain hemp oil procured through a patent pending hemp oil extraction process. Crop has the right to add hemp oil to the products and distribute them throughout Italy.
According to a study by Arcview Market Research and its research partner BDS Analytics, by 2027 worldwide sales of legal cannabis are forecast to reach $57 billion. During that period, spending in North America is expected to leap from $9.2 billion to $47.3 billion driven mainly be recreational use. The fastest cannabis market growth is expected to come from outside North America, especially Europe where the main growth driver will be medical applications. Medical cannabis use will be fed by $1.3 trillion estimated annual government-subsidized healthcare spending. The structure of the healthcare industry is expected to make Europe the number one medical cannabis market in the world.
“We are excited to be partnered with CROP for the European launch of the URBAN JUVE hemp oil infused product line,” says Penny Green, President and CEO of Yield Growth. “CROP is a demonstrated leader in the international hemp market with affiliations to hemp production in Nevada, California, Washington, Italy and Jamaica.”
CROP Infrastructure Director & CEO Michael Yorke states: “We are pleased with the URBAN JUVE branding initiative by Yield Growth and feel it will resonate with health and lifestyle consumers. We look forward to offering the URBAN JUVE products in Italy.”
About CROP Infrastructure Corp.
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of assets includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 16 Cannabis brands and has US and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.
Company Contact
Michael Yorke – CEO & Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home
CROP’s Wheeler Facility Commences Commercial Production
Momentum Public Relations
Press Release: August 28, 2018
CROP Infrastructure Corp. (CSE: CROP.CN) (OTCMKTS: CRXPF) (CROP.CN) (“CROP” or the “Company”) announced today that its tenant has now commenced commercial production at Wheeler Park. The facility is designed for perpetual harvest of cannabis at ‘The Park’, its state-of-the-art facility in Washington State. Crop’s licensed tenant grower has now advised the Company that it expects its first harvest of cannabis within weeks and it will be at full scale production in September 2018. The perpetual harvest system utilizes cannabis strains with a 55-60 day flower cycle. Every other day the tenant grower removes three trays of flowered plants from the finishing end and harvests the plants, while simultaneously loading three new trays with plants to begin the flowering process.
The Park cannabis greenhouse is 35,000 sqft and sits on approximately nine acres of land. The facility recently underwent a complete retro-fit for hydroponic automation and the addition of 500 Gavita HPS grow lights. The greenhouse facility has five flowering bays that are designed to yield, at full scale production, approximately 12,000 pounds of high quality cannabis annually (~1,000 pounds per month). The current operating cost is $50,000 USD per month.
CROP Infrastructure Director and CEO, Michael Yorke, stated: “With harvests now underway in Californiaalong with our Washington tenant weeks away from its first harvest, the Company is now at a turning point. The Company expects four of its six tenant licensees to harvest at its farms, with each set to begin cash flowing in Q4 2018.”
About CROP Infrastructure Corp.
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of assets includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 16 Cannabis brands and has US and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.
Disclaimer for Forward-Looking Information
Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected yield from The Jamaica Property; the technological effects of The Jamaica Property on production; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Company Contact
Michael Yorke – CEO & Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
View original content:http://www.prnewswire.com/news-releases/crops-wheeler-facility-commences-commercial-production-300702936.html
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home
DIAGNOS Announces Private Placement of Common Stocks and Stock Warrants
Momentum Public Relations
Press Release: August 24, 2018
DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces a private placement (“Private Placement”) of up to 1,333,333 units (each a “Unit”) issued at $0.075 per Unit for gross proceeds of up to $100,000. Each Unit consists of;
- one common share (“Share”), and
- one stock warrant (“Warrant”) entitling the holder to purchase one Share per Warrant at a price of $0.10 per Share, for a period of 18 months from the date of issuance of the Warrant.
The proceeds will be used to fund marketing and administrative expenses.
Shares issued as part of the Private Placement as well as the underlying Shares to be issued upon exercise of the Warrants are subject to a statutory four-month hold period from the date of issuance.
Closing of the Private Placement is scheduled for August 30, 2018. The Private Placement is subject to receipt of all required regulatory approvals, including the approval of the TSX Venture Exchange, as well as the execution of formal documentation.
All monies quoted in this press release shall be stated and paid in lawful money of Canada.
About DIAGNOS
DIAGNOS is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence (“AI”) tool CARA (Computer Assisted Retina Analysis). CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care. CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost-effective tool for screening large numbers of patients in real-time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration and the European Union.
Additional information is available at www.diagnos.com and www.sedar.com.
For further information, please contact:
Mr. André Larente, President | Josh Falle |
DIAGNOS Inc. | Momentum PR |
Tel: 450-678-8882 ext. 224 | Tel: 514-416-4656 |
alarente@diagnos.ca | josh@momentumpr.com |
- Published in Business, Diagnos, Life Sciences, News Home, Technology
Former CEO of Jamaica’s Cannabis Licensing Authority Joins CROP’s Executive Advisory Team
Momentum Public Relations
Press Release: August 23, 2018
CROP Infrastructure Corp. (CSE: CROP) (OTCMKTS: CRXPF) (“CROP” or the “Company”) announced today the appointment of Greg Douglas to the Executive Advisory Board who will have a special focus on CROP’s Jamaica operations.
CROP Infrastructure CEO, Michael Yorke, stated, “Greg can be considered one of the foremost authorities on the Jamaican cannabis industry. He will be of considerable assistance to CROP as the business develops there.
“Greg has the invaluable ability to effectively interact with stakeholders from both the private and public sectors and his knowledge of the industry, both in the Caribbean and North America, is truly extensive and that will be of great benefit to CROP as it expands even further internationally.”
Greg Douglas formally entered the Cannabis space in 2015 when he joined the Bureau of Standards Jamaica as their Management Information Systems (MIS) Manager. Shortly after joining the Bureau he was named as the Project Coordinator for a proposed Medical Cannabis (Ganja) Track and Trace Pilot Project.
Through this Greg was exposed to compliance mechanisms used in Colorado, touring state facilities which increased his understanding and appreciation of the industry while building relationships with Colorado’s compliance agency, along with local businesses.
Greg is now known internally at the Bureau as the ‘Ganja Man’ and externally by stakeholders as the ‘Bureau Man’. During April to November 2017 Greg was seconded to the Cannabis Licensing Authority (CLA) as their CEO. While there he became a part of history issuing the first commercial licenses.
He also sought to streamline internal processes to increase the efficiency of the Authority. He was part of the CLA team that visited Canada where the team met with both Canadian Government entities and officials (Health Canada, MP Bill Blair, Department of Finance), also with resident offices of the Jamaica Tourist Board and JAMPRO.
Greg resumed his duties at the Bureau of Standards in January 2018 and is engaged as a member of the team responsible for the creation of standards within the cannabis industry in Jamaica.
About CROP Infrastructure Corp.
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of assets includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 16 Cannabis brands and has US and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.
Company Contact
Michael Yorke – CEO & Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home
CROP’s Nevada Hemp Farm Adds 750 Acres of Production Land for 2019 Season
Momentum Public Relations
Press Release: August 22, 2018
CROP Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) (“CROP“ or the “Company“) announced today its Nevada subsidiary has leased an additional 750 acres of contiguous agricultural farmland bringing the total Nevada acreage to 1,065 acres with 240 acres under pivot.
The lease also provides access to over 300 acres of additional water rights. The additional 750 acres of pivot development potential will substantially increase production for the 2019 season.
The newly-leased acreage comes with four housing units and a building to be converted into an extraction facility to process hemp biomass for CBD isolate on site. The two-year lease will annually cost $566 USD per acre and the company intends to use a portion of the revenue from its first crop to pay for the lease.
The previously announced 240 acres of CBD Hemp was planted and is currently 1.5 feet tall and growing under pivot. All harvesting equipment has been secured for the resulting hemp biomass. It is estimated that the 240 acre pivots will yield 240,000 pounds of hemp flower. The cost of production is not expected to exceed $700,000 USD with many of the costs already incurred. The first harvest is expected in early Q4 this year.
CROP Infrastructure Director and CEO, Michael Yorkestated: “As previously announced in July, our Nevada Hempfarm and licensed tenant became the largest hemp farmer in Nevada in 2018. We are confident with over 1,000 acres that our tenant will remain the largest hemp farm in Nevada. The next phase of development will be a state-of-the-art extraction facility to make high-value CBD isolate.”
About CROP
Crop Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California and Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 16 Cannabis brands and has US and Italian distribution rights to a line of over 55 cannabis topical products from The Yield Growth Corp.
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home
Crop Advances Its San Bernardino Dispensary Application and Increases Ownership in California Farm
Momentum Public Relations
Press Release: August 15, 2018
CROP Infrastructure Corp. (CSE: CROP) (OTCMKTS: CRXPF) (“CROP” or the “Company”) announces it has received confirmation that its San Bernardino dispensary application has passed stage one of the application review process. As previously announced on July 5th 2018, CROP has agreed to finance the purchase of real estate on the granting of a California dispensary license. The proposed dispensaries will operate under the brand, “Emerald Heights”.
Furthermore, the Company is pleased to announce it has increased its ownership from 30% to 49% for its “Emerald Triangle” cannabis production facility tenanted by “Hempire” in Humboldt California. This 30,000 square foot production facility sits on approximately nine acres and consists of a 10,000 square foot medicinal cannabis greenhouse facility and an additional 20,000 square feet of recreational licensed canopy.
As previously announced on August 9th 2018, harvesting at the Humboldt operation recently began at the first of five 2,000 square foot greenhouses and is expected to continue at a rate of one greenhouse per week. As each greenhouse is harvested new starter plants will populate the canopy space. Once the 10,000 square feet of plants have been taken down, the additional 20,000 square feet of canopy will then be harvested.
CROP Infrastructure Director & CEO Michael Yorke states: “This is an exciting time for CROP as our tenant begins its first harvest in California which makes this an ideal time to increase our ownership in the project from 30% to 49%. Our Humboldt facility is located in one of the most important cannabis jurisdictions in the US and potentially the world known as the Emerald Triangle. With the advancement of our dispensary application we are now moving towards assisting tenants in becoming fully vertically integrated in the State of California.”
The Company will purchase the additional 20% of Humboldt for total consideration of $1.0 Million CAD by issuing 5,000,000 shares at a deemed price of $0.20 per share; 100% of these shares will be escrowed for 12 months, with 25% becoming free trading every 3 months thereafter.
About Humboldt Holdings LLC
Located in Humboldt County, California the property is 8.46 acres and currently houses a 10,000 square foot greenhouse as well as a barn, garage and residence. On site are five 5,000-gallon water tanks, a well and pump house and a 30 x 60 ft. drying shed. The property is zoned for a 10,000 square foot medical and a 20,000 square foot recreational cannabis license.
https://cropcorp.com/property/california/
About CROP
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 15 Cannabis brands and has US and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.
Company Contact
Michael Yorke – CEO & Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home
CROP & Naturally Splendid Enter Into Manufacturing and Supply Agreement for Hemp Products
Momentum Public Relations
Press Release: August 14, 2018
CROP Infrastructure Corp. (CSE: CROP) (OTCMKTS: CRXPF) (“CROP” or the “Company”)announces that it has signed a Letter of Intent (“LOI”) with Naturally Splendid Enterprises Ltd. (“Naturally Splendid,” “NSE” or “the Company”)(FRANKFURT:50N)(TSX-V:NSP)(OTC:NSPDF) for the development and manufacturing of The Hempire Co. “Hempire” and Tiffany “TiffCBD”, branded Hemp Seed, Hemp Protein Powder and Hemp Oil product lines to be owned by CROP. Naturally Splendid and CROP are currently testing a variety of existing as well as unique flavors and formulations created by NSP specifically for the Hempire and TiffCBD Brands, some of which will have products enhanced with NSP’s HempOmega™.
Visit The Hempire and TiffCBD websites at: (www.thcco.com) and (www.tiffcbd.com)
Under the terms of the agreement, Naturally Splendid will create a variety of retail products, initially based on hemp seed, protein and oil and will be expanded to include CBD (cannabidiol) fortified products as regulations evolve to allow for cannabis extract, formulated products. These products will be marketed and distributed though CROP’s growing distribution network.
HempOmega™ is a soluble powder created from microencapsulated hemp seed oil delivering essential omega 3 and 6 fortification to a wide variety of products and beverages. It is a high-quality and sustainable omega fatty acid alternative ingredient to fish oil. Due to its unique powder format, it solves the formulation challenge manufacturers face when trying to add oil to existing products and has proven to increase the bioavailability of omega fatty acids.
Michael Yorke, CEO of CROP Infrastructure states: “We are excited to be working with Naturally Splendid who was an early mover in the Canadian Hemp market. We believe in the nutritional spectrum and health benefits of hemp and adding a consumer goods vertical was a logical progression as consumer data shows strong trends in plant-based foods and nutritional products. We are very pleased to bring our Hempire brand to Canada which will now be under license in 3 US States and collectively 4 countries worldwide.”
Craig Goodwin, President and director of Naturally Splendid states: “We are pleased to be working with CROP to create quality white-labelled hemp products for the Hempire brand. Naturally Splendid and CROP are developing several new hemp-based formulations that will be enhanced with our patented HempOmega™ ingredient.”
About CROP
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 15 Cannabis brands and has US and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.
Company Contact
Michael Yorke – CEO & Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home